Zithromax and Psoriasis aggravated - a phase IV clinical study of FDA data

Summary:

Psoriasis aggravated is reported as a side effect among people who take Zithromax (azithromycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Otezla, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Psoriasis aggravated when taking Zithromax. It is created by eHealthMe based on reports of 34,614 people who have side effects when taking Zithromax from the FDA, and is updated regularly.

What is Zithromax?

Zithromax has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 35,525 Zithromax users. Check the latest studies of Zithromax.

What is Psoriasis aggravated?

Psoriasis aggravated (immune-mediated disease that affects the skin) is found to be associated with 1,292 drugs and 474 conditions by eHealthMe. Check the latest studies of Psoriasis aggravated.

On Aug, 10, 2026

34,614 people reported to have side effects when taking Zithromax.
Among them, 67 people (0.19%) have Psoriasis aggravated.

Could Zithromax cause Psoriasis aggravated?

Among these 67 people:

How long have people been on Zithromax when they have Psoriasis aggravated? *

What is the gender of people who have Psoriasis aggravated when taking Zithromax? *

female: 75 %
male: 25 %

What is the age of people who have Psoriasis aggravated when taking Zithromax? *

What are other drugs people take besides Zithromax? *

What are other side effects people have besides Psoriasis aggravated? *

Joint Pain: 12 people, 17.91%
Rashes (redness): 11 people, 16.42%
Nasopharyngitis (inflammation of the nasopharynx): 9 people, 13.43%
Diarrhea: 8 people, 11.94%
Pain: 8 people, 11.94%
Drowsiness: 8 people, 11.94%
Pneumonia: 7 people, 10.45%
Drug Ineffective: 7 people, 10.45%
Weakness: 6 people, 8.96%
Itching: 6 people, 8.96%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 14.93%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 14.93%
High Blood Pressure: 7 people, 10.45%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 7.46%
Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 4 people, 5.97%
Upper Respiratory Tract Infection: 4 people, 5.97%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 5.97%
Diabetes: 4 people, 5.97%
High Blood Cholesterol: 3 people, 4.48%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 4.48%

* Approximation only. Some reports may have incomplete information.

Do you take Zithromax and have Psoriasis aggravated?

- Check whether Psoriasis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zithromax:

Zithromax (35,525 reports)

Browse all side effects of Zithromax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis aggravated:

Psoriasis aggravated (1,292 drugs)

Browse all the conditions that are associated with Psoriasis aggravated:

Psoriasis aggravated (474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azithromycin (the active ingredients of Zithromax) and Zithromax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.